BXP vs CUE · rev $3.48B vs rev $9.3M
Boston Properties Inc (BXP) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
BXP currently screens at market cap $12.12B. CUE currently screens at market cap $59.5M.
Not investment advice. Open the BXP and CUE stock pages for the full models.
Not investment advice.